期刊文献+

P糖蛋白与难治性癫痫关系的研究进展 被引量:2

Research progress on the relationship between P glycoprotein and intractable epilepsy
原文传递
导出
摘要 作为ATP-结合盒跨膜转运蛋白的其中一员,P糖蛋白(P-gp)扮演着清除外源生命体和细胞毒素的生理屏障角色。它在人体组织中分布广泛,功能多样,充当血脑屏障破坏后的第二屏障。研究发现,P-gp与难治性癫痫(RE)密切相关,是RE的主要发病机制之一,是国内外研究的热点。本文通过综述P-gp的结构、分布、生物学功能、调控机制及其与RE的关系,为RE的靶向治疗提供新的理论依据,对提高RE的防治水平具有重要价值。 As a member of ATP-binding cassette transmembrane transport protein, P-glycoprotein (P-gp)plays a role as a physiological barrier to removing exogenous and cellular toxins. P-gp is widely distributed in the human body and has a lot of functions, which acts as the second barrier after the destruction of blood brain barrier. Studies have found that P-gp is closely related to refractory epilepsy(RE) and it is one of the main pathogenesis of RE, which is a hot research topic at home and abroad. The structure, distribution, biological function and regulation mechanism of P-gp and its relationship with RE refractory epilepsy were reviewed in this paper, which can provide a new theoretical basis for the targeted therapy of RE and is of great value in improving the level: of prevention and treatment of RE.
作者 高敏 张敬军
机构地区 泰山医学院
出处 《中华脑科疾病与康复杂志(电子版)》 2016年第2期120-123,共4页 Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition)
基金 山东省医药卫生科技发展计划(2014WS0196) 山东省高等学校科技计划(J15LL07) 首都医科大学重点实验室开放研究课题(2016-1)
关键词 癫痫 基因表达调控 P糖蛋白 P糖蛋白抑制剂 Epilepsy Gene expression regulation P glycoprotein P glycoprotein inhibitors
  • 相关文献

参考文献3

二级参考文献59

  • 1马秉亮,吴玉林,刘国卿.P-gp及对抗P-gp介导多药耐药的研究现状[J].中国临床药理学与治疗学,2006,11(1):14-21. 被引量:15
  • 2Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 2003; 348: 1442-8.
  • 3Lazarowski A, Czornyj L. Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions. Drug Metabol Drug Interact 2011; 26: 21-6.
  • 4Baguley BC. Multiple drug resistance mechanisms in cancer. Mol Biotechnol 2010; 46: 308-16.
  • 5Hipfner DR, Deeley RG, Cole SP. Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta 1999; 1461: 359-76.
  • 6Morimoto K, Goddard GV. Seizure-triggering mechanism in the kindling model of epilepsy: I. EEG changes during stimulation fromthe site of stimulation. Jpn J Psychiatry Neurol 1988; 42: 618-9.
  • 7Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972; 32: 281-94.
  • 8Walker MC, Alavijeh MS, Shorvon SD, Patsalos PN. Microdialysis study of the neuropharmacokinetics of phenytoin in rat hippocampus and frontal cortex. Epilepsia 1996; 37: 421-7.
  • 9Iram SH, Cole SP. Expression and function of human MRP1 (ABCC1) is dependent on amino acids in cytoplasmic loop 5 and its interface with nucleotide binding domain 2. J Biol Chem 2011; 286: 7202-13.
  • 10Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000; 92: 1295-302.

共引文献13

同被引文献19

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部